Rare diseases
Investigational molecules
Locations
Back to Greece1 008 clinical trials in Chaidari, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)Study of Cemiplimab Alone and with RP1 for Patients with Advanced Skin Squamous Cell Carcinoma
GreeceStudy on Bepirovirsen for Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue Treatment
GreeceStudy of RO7247669 at Different Doses for People with Previously Untreated Advanced Melanoma that Cannot be Removed by Surgery or Has Spread
GreeceStudy on Dexamethasone and Sodium Chloride for Treating Severe Hospital-Acquired Pneumonia in Critically Ill Patients with a Proinflammatory Profile
GreeceStudy of Nivolumab and Ipilimumab for Patients with Advanced Kidney Cancer and Intermediate or Poor Risk Factors
GreeceStudy on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy
GreeceStudy on Efgartigimod Alfa and Prednisone for Adults with Bullous Pemphigoid
GreeceStudy Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations
GreeceStudy of Venetoclax and Azacitidine for Maintenance Therapy in Patients with Acute Myeloid Leukemia in First Remission After Chemotherapy
GreeceStudy on Atezolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer with Positive ctDNA After Surgery
GreeceStudy of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery
GreeceStudy on the Safety and Effectiveness of Ocrelizumab vs. Fingolimod for Children and Adolescents with Relapsing-Remitting Multiple Sclerosis
GreeceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on squamous cell carcinoma of the head and neck, exploring combination therapy approaches that integrate immunotherapy with traditional treatments.
The study evaluates the effectiveness of combining nivolumab with standard cisplatin-radiotherapy, aiming to improve disease-free survival rates in patients with resected head and neck cancer.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
